These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 304190)

  • 1. "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity.
    Bedard P; Pycock CJ
    Neuropharmacology; 1977 Oct; 16(10):663-70. PubMed ID: 304190
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat.
    Yap CY; Taylor DA
    Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of serotoninmimetics in the behavioral despair test in rats.
    Górka Z; Wojtasik E; Kwiatek H; Maj J
    Commun Psychopharmacol; 1979; 3(3):133-6. PubMed ID: 315302
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological profile of a model for central serotonin receptor activation.
    Matthews WD; Smith CD
    Life Sci; 1980 Apr; 26(17):1397-403. PubMed ID: 6247593
    [No Abstract]   [Full Text] [Related]  

  • 6. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of some drugs affecting brain 5-HT on the aggressive behaviour and spontaneous electrical activity of the central nervous system of the ant, Formica rufa.
    Kostowski W; Tarchalska B
    Brain Res; 1972 Mar; 38(1):143-9. PubMed ID: 4536925
    [No Abstract]   [Full Text] [Related]  

  • 11. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the locomotor effects of 5-hydroxytryptamine and 5-hydroxytryptophan administered via two systemic routes.
    Jacobs BL; Eubanks EE
    Pharmacol Biochem Behav; 1974; 2(1):137-9. PubMed ID: 4545332
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of apomorphine hypothermia by drugs affecting brain 5-hydroxytryptamine function.
    Menon MK; Vivonia CA
    Eur J Pharmacol; 1981 Dec; 76(2-3):223-7. PubMed ID: 7333357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal 5-hydroxytryptamine receptors outside the central nervous system.
    Wallis D
    Life Sci; 1981 Dec; 29(23):2345-55. PubMed ID: 7033702
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin-sensitive adenylate cyclase activity of immature rat brain.
    von Hungen K; Roberts S; Hill DF
    Brain Res; 1975 Feb; 84(2):257-67. PubMed ID: 1078637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metoclopramide antagonism of 5-hydroxytryptophan-induced "wet-dog" shake behaviour in the rat.
    Fozard JR; Palfreyman MG
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jun; 307(2):135-42. PubMed ID: 314597
    [No Abstract]   [Full Text] [Related]  

  • 18. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
    White FJ; Appel JB
    Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of "wet shakes" during morphine abstinence by an antagonist of opiate analgesia.
    Vetulani J; Bednarczyk B; Reichenberg K
    Eur J Pharmacol; 1978 Aug; 50(3):261-4. PubMed ID: 308460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.